Jeffrey S. Heier Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Jeffrey S. Heier is Chief Scientific Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 265,998 shares of OCUL, which is worth approximately $1.73 Million. The most recent transaction as insider was on Feb 24, 2025, when has been sold 3,061 shares (Common Stock) at a price of $6.87 per share, resulting in proceeds of $21,029. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 266K
1.14% 3M change
343.83% 12M change
Total Value Held $1.73 Million

Jeffrey S. Heier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
SELL
Open market or private sale
$21,029 $6.87 p/Share
3,061 Reduced 1.14%
265,998 Common Stock
Nov 25 2024
SELL
Open market or private sale
$26,561 $9.01 p/Share
2,948 Reduced 1.08%
269,059 Common Stock
Oct 02 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 26.88%
272,007 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
12,000 Added 16.68%
59,933 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
8,933 Added 15.71%
47,933 Common Stock
May 12 2022
BUY
Open market or private purchase
$45,750 $3.05 p/Share
15,000 Added 27.78%
39,000 Common Stock
JSH

Jeffrey S. Heier

Chief Scientific Officer
Bedford,, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL